|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.380 USD | +4.85% |
|
-3.25% | -17.07% |
| 12-30 | Definitive Healthcare Corp.'s Equity Buyback announced on November 7, 2024, has expired. | CI |
| 11-11 | Deutsche Bank Raises Price Target on Definitive Healthcare to $6 From $5, Keeps Hold Rating | MT |
| Capitalization | 234M 200M 186M 175M 324M 21.48B 347M 2.14B 845M 10.15B 879M 861M 37.08B | P/E ratio 2025 * |
-1.66x | P/E ratio 2026 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise value | 212M 181M 168M 158M 293M 19.42B 314M 1.93B 764M 9.18B 795M 779M 33.53B | EV / Sales 2025 * |
0.89x | EV / Sales 2026 * | 0.81x |
| Free-Float |
30.36% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Definitive Healthcare Corp.
| 1 day | +5.29% | ||
| 1 week | -3.25% | ||
| Current month | -17.07% | ||
| 1 month | -5.93% | ||
| 3 months | -19.87% | ||
| 6 months | -40.35% | ||
| Current year | -17.07% |
| 1 week | 2.26 |  | 2.48 |
| 1 month | 2.26 | | 2.88 |
| Current year | 2.26 | | 2.87 |
| 1 year | 2.15 | | 5.68 |
| 3 years | 2.15 | | 14.03 |
| 5 years | 2.15 | | 50.3 |
| 10 years | 2.15 | | 50.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin Coop
CEO | Chief Executive Officer | 61 | 23/06/2024 |
Casey Heller
DFI | Director of Finance/CFO | 37 | 01/06/2025 |
Ben Graboske
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Krantz
CHM | Chairman | 53 | 31/01/2011 |
Jeff Haywood
BRD | Director/Board Member | 47 | 31/01/2015 |
Lauren Young
BRD | Director/Board Member | 43 | 30/06/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.86% | 0.25% | 17 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.85% | -3.25% | -46.03% | -80.12% | 234M | |
| -2.29% | -3.32% | +3.64% | +83.08% | 3,378B | |
| -1.90% | -7.33% | +126.26% | +2,140.24% | 402B | |
| +2.15% | +3.29% | -1.47% | +48.99% | 97.76B | |
| +2.23% | +0.21% | +0.92% | +71.11% | 83.57B | |
| +0.81% | -3.85% | +118.99% | +2,118.37% | 81.37B | |
| -0.07% | -3.29% | +2.51% | +81.52% | 71.76B | |
| -4.01% | -8.68% | +14.49% | +107.29% | 55.34B | |
| -0.99% | -2.96% | +28.68% | +115.27% | 44.46B | |
| +0.09% | -3.81% | -32.53% | -31.53% | 36.13B | |
| Average | +0.35% | -4.87% | +21.55% | +465.42% | 425.05B | |
| Weighted average by Cap. | -1.80% | -3.76% | +17.34% | +315.07% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 240M 205M 190M 178M 331M 21.94B 354M 2.18B 863M 10.37B 898M 880M 37.88B | 234M 200M 185M 174M 323M 21.4B 345M 2.13B 842M 10.11B 876M 858M 36.94B |
| Net income | -162M -139M -129M -121M -224M -14.87B -240M -1.48B -585M -7.03B -609M -597M -25.68B | -19.11M -16.34M -15.17M -14.22M -26.39M -1.75B -28.26M -174M -68.88M -827M -71.66M -70.19M -3.02B |
| Net Debt | -22.44M -19.19M -17.81M -16.7M -30.99M -2.06B -33.18M -204M -80.89M -971M -84.15M -82.43M -3.55B | -44.56M -38.1M -35.36M -33.17M -61.53M -4.08B -65.89M -406M -161M -1.93B -167M -164M -7.05B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/01/26 | 2.380 $ | +4.85% | 435,067 |
| 20/01/26 | 2.270 $ | -5.02% | 352,893 |
| 16/01/26 | 2.390 $ | -1.65% | 245,373 |
| 15/01/26 | 2.430 $ | -1.22% | 308,670 |
| 14/01/26 | 2.460 $ | -0.40% | 282,764 |
Delayed Quote Nasdaq, January 21, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition